Menu
Back to Journals » Clinical and Experimental Gastroenterology » Volume 11
Original Research
A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,612 | Dovepress* | 6,329+ | 782 | 7,111 | |
| PubMed Central* | 283 | 87 | 370 | ||
| Totals | 6,612 | 869 | 7,481 | ||
| *Since 24 October 2018 | |||||
View citations on PubMed Central and Google Scholar